Milestone Pharmaceuticals (MIST) Finished Goods (2025 - 2026)
Milestone Pharmaceuticals (MIST) posted Finished Goods of $213000.0 for Q1 2026, up 67.72% on a QoQ basis from $127000.0 in Q4 2025.
Milestone Pharmaceuticals (MIST) Finished Goods (2025 - 2026) Analysis & Trends
Milestone Pharmaceuticals' Finished Goods history runs 2 years deep, the most recent figure standing at $213000.0 for Q1 2026.
- Quarterly Finished Goods changed N/A year-over-year to $213000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $213000.0 (changed N/A YoY) and the FY2025 annual result came in at $127000.0, changed N/A from the prior year.
- Finished Goods was $213000.0 for Q1 2026 at Milestone Pharmaceuticals, up from $127000.0 in the prior quarter.
- Across five years, Finished Goods topped out at $213000.0 in Q1 2026 and bottomed at $127000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 213,000.00 |
| Dec 31, 2025 | 127,000.00 |